The recent funding cuts have raised significant concerns regarding the impact on medical research safety, particularly in how they compromise patient protections in clinical trials.These cuts, exemplified by the freeze on over $2 billion in National Institutes of Health (NIH) funding, disrupt the crucial oversight mechanisms that safeguard human participants involved in medical studies.